Last reviewed · How we verify

Oxytocine

University Hospital, Limoges · discontinued Small molecule

Oxytocine is a Small molecule drug developed by University Hospital, Limoges. It is currently in discontinued development.

At a glance

Generic nameOxytocine
SponsorUniversity Hospital, Limoges
ModalitySmall molecule
Therapeutic areaOther
Phasediscontinued

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oxytocine

What is Oxytocine?

Oxytocine is a Small molecule drug developed by University Hospital, Limoges.

Who makes Oxytocine?

Oxytocine is developed by University Hospital, Limoges (see full University Hospital, Limoges pipeline at /company/university-hospital-limoges).

What development phase is Oxytocine in?

Oxytocine is in discontinued.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing